<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=1000083763474443&amp;ev=PageView&amp;noscript=1">

SmartTRAK Life Sciences News and Analysis Blog

9 min read

What's New in Orthopedics Research & Development

By Thomas Wallick on 2/27/23 11:28 AM

In recent years, there have been significant advances in orthopedic treatments, surgical techniques and rehabilitation methods that have transformed the way we approach musculoskeletal disorders.SmartTRAK continues to report daily, in real-time. on the challenges still ahead, covering all aspects of the Orthopedic market: Extremities, OrthoBio, Spine, Computer Assisted Surgery, Total Joints, Trauma, Soft Tissue Fixation and EU Extremities and Trauma.

SmartTRAK features curated content by our team of industry experts, bringing the most relevant information and insight directly to you in real-time. Learn about the latest news, emerging technologies or start-ups to watch, conference happenings and more via articles, videos and interviews and Be The Expert.

The following is just a small sampling of recent Orthopedic updates from around the world compiled, reviewed and posted daily by our SmartTRAK analysts.

New Products:

  • NuVasive*

    NUVA spoke about its upcoming product launches, including an expandable Lateral called MOD-EX XLIF and extended blade-fixation options for Modulus ALIF, and predicted that both will support the continued interest in NUVA. NUVA Q422 Earnings Transcripton Seeking Alpha

  • GMED mgmt stated the ortho robot will launch w/ a knee application first w/ other applications to follow, noting it is unlikely that gap-filling joint implant systems would be launched prior to the knee application for robotics. GMED Q422 Earnings Transcript on Seeking Alpha

  • CurvaFix announced a it will launch the 7.5 mm CurvaFix IM Implant, which received FDA clearance in Oct 2022, at this year’s AAOS annual meeting in Las Vegas. BusinessWire


  • SeaSpine*

    7D Surgical was granted US Patent “Systems And Methods For Intraoperative Spinal Level Verification” disclosing the use of segmented surface data from volumetic pt image data compared w/ intra-op surface data to verify spine levels w/o x-rays. 11564752

  • Method for Treating Joint Pain  

    US Patent "Method for treating joint pain" was granted relating to treating joint pain by inserting a bone dowel and BMA into the subchondral of a bone and introducing BMA into the intra-articular space of the joint being treated. 11583402

Continue Reading
3 min read

Meet The Expert: Neil Beals - Senior Analyst, Spine & Spine Biologics

By Thomas Wallick on 2/6/23 3:05 PM

We are pleased to announce that Neil Beals has joined the team at SmartTRAK as our new Senior Analyst, Spine and Spine Biologics. Neil has 30+ years’ experience working in leadership roles in R&D, technology management, marketing and market development, with extensive responsibilities in identifying, developing, and commercializing new technologies. His experience includes executive management positions at Smith & Nephew, Medtronic Spine & Biologics, Ellipse Technologies and Nuvasive Specialized Orthopedics along with consulting with innovative medical device start-ups.

Meet Neil Beals:

What is your role with SmartTRAK? I am a Senior Analyst for Spine and Spine Biologics.

What do you like about SmartTRAK? I like the fact that SmartTRAK is the leader in market intelligence for the highly competitive life sciences industry.  I also like that SmartTRAK provides a unique resource for a wide range of stakeholders.  The SmartTRAK team has tremendous industry-related experience and works collaboratively in pursuing opportunities, addressing challenges and responding to its subscribers.

Continue Reading
2 min read

A Shifting Procedural Landscape: Q322 Spine Market Recap

By Courtney Sheedy on 1/12/23 9:52 AM

SmartTRAK reports that Q322 Spine Market performance drove a lack of consensus on operational performance metrics, while a shifting procedural landscape offered new product opportunities for small and mid-tier players, driving competitive pressure.

Among the many topics covered in detail in our comprehensive Q322 Spine Market Recap* are:

Continue Reading
2 min read

A Tidal Wave of Competitors: Q322 CAS Spine Market Recap

By Shelly Caruso on 12/19/22 6:41 PM

Q322 sees a tidal wave of new robotic spine surgery competitors as well as data-driven initiatives under development by a host of companies in the market for spine enabling tech.

Q322 was nothing short of a tidal wave of competitive entrants to the US Spine Robotic Surgery space. Medtronic* (MDT) and  Globus* remain top players as OUS companies like France’s  eCential Robotics* and Taiwan’s  Point Robotics MedTech* set their sights on the US market. The Q322 WW CAS Spine Market was up, according to  SmartTRAK Financial Dashboard. MDT remained the market leader with 49.0% share, followed by Globus and other enabling tech competitors like Brainlab* and Stryker* (SYK).

Among the many topics covered in detail in our comprehensive Q322 CAS Spine Market Recap* are:

Continue Reading
3 min read

Bolt Navigation: Simplifying Spinal Navigation-An Interview with CEO Patrick West

By Shelly Caruso on 12/12/22 10:00 AM

SmartTRAK interviews Bolt Navigation CEO Patrick West to learn more about the Company and its potentially disruptive solution for streamlined spinal navigation.

One of the most exciting enabling technologies on display at the recent North American Spine Society (NASS) 2022 annual meeting in Chicago was the Bolt Navigation System, a novel, FDA-pending technology developed by Bolt Navigation to simplify spinal navigation. Designed by a practicing neurosurgeon, Bolt utilizes a software application to leverage the positional guidance inherent in an iPhone for intraoperative spine screw planning and placement guidance. The system works without a reference frame and can be used with a patient's diagnostic MRI or CT and a single C-arm shot once the patient is positioned. It is implant agnostic and can be attached to almost any instrument.

To find out more about Bolt Navigation and this potentially disruptive solution for streamlined spinal navigation, listen to SmartTRAK’s interview with CEO Patrick West in the following video (30:47 min). A link to a transcript of the complete interview is also provided below.

Continue Reading
3 min read

SmartTRAK is Seeking a Senior Analyst: Spine and OrthoBiologics/Regen

By Sharon O'Reilly on 12/6/22 4:08 PM

Do you love keeping up with the latest trends in the Spine and OrthoBiologics/Regen medicine markets? Are you a closet investigative reporter who loves researching and analyzing what’s going on in the market? Are you looking for a position that leverages your industry knowledge, expertise and connections in new ways? If you are a current or former marketing, market research or business development professional who has worked with one of the major orthopedic/spine companies and looking for a career change, we would love to talk with you.

We are looking to strengthen our SmartTRAK Spine and OrthoBiologics/Regen modules with the addition of a qualified person with industry specific experience. All SmartTRAK analysts are former marketing, business development or R&D professionals with one of the major orthopedic/spine suppliers and, in fact, most have come to us via recommendations from our subscribers, as well as those in the industry. We believe that having a person of this caliber with relevant experience and deep insight on the market is a tremendous value-add we can offer SmartTRAK subscribers.

We are looking for someone with Spine and OrthoBiologics/Regen industry experience who is interested in working full-time. Click the button below to learn more and apply. Learn More and Apply

Continue Reading
2 min read

Key Trends in Enabling Technology for Spine: NASS 2022

By Elise Wolf on 11/28/22 10:18 AM

For the first time in recent years, robotics was not a main headline in the academic program at NASS 2022, but SmartTRAK notes that the exhibit floor was buzzing with exciting new developments in enabling technology.

Although there were limited program sessions focused solely on enabling technology at NASS 2022, the floor was abuzz with digital solutions, including recently launched and upcoming products. Based on conversations with NASS exhibitors, SmartTRAK identified key trends in the market for spine enabling technology including new spine robotic systems, augmented reality (AR) platforms and compact navigation solutions, as well as advances in surgical planning and unveiling of digital ecosystems. These innovations will help drive double-digit growth in the US market for Spine Enabling Technologies.

Among the many topics covered in detail in the complete article, which can be downloaded here, are:

  • Beyond Robotics: Leveraging Data and Ecosystems
  • Battle Bots: New Spine Robots on Display
  • Augmented Reality Positioned to Target ASCs
  • Small-Footprint Platforms and Disposable Spinal Navigation
  • Problem-Solving Differentiated Technology
Continue Reading
2 min read

NASS 2022: Emerging Markets and Trends in Spine

By Courtney Sheedy on 11/3/22 9:30 AM

SmartTRAK identified several trends at NASS 2022 that have the potential to improve patient care and drive advancement in the spine market, including the shift of fusion procedures to the ASC setting, a potential tipping point for the adoption of endoscopic spine care, and emerging innovations within the interbody space.

At the North American Spine Society (NASS) 2022 Annual Meeting in Chicago, SmartTRAK witnessed a revival in energy that has been absent in recent years due to COVID-19, healthcare disruption and industry M&A integration. Exhibitors had the opportunity to teach attendees about new technology in a multitude of ways – a new live surgical theater was proudly projected throughout the exhibit hall and most companies were equally inviting to conversations about macro technology developments. Though SmartTRAK has seen so much innovation in spine over the recent several years, which of these advancements will truly lead to improved patient care? SmartTRAK identified several trends at NASS 2022 that have the potential to improve patient care and drive growth in the spine market over the coming two-to-five years. These include the shift of procedures from the hospital to outpatient and ambulatory surgery center (ASC) settings, increased adoption and adaptation within surgical approaches and the introduction of custom interbody implants, and many others.

Among the many topics covered in detail in this article are:

Continue Reading
2 min read

Orthofix & SeaSpine Merge: Create a Leading Global Spine and Orthopedics Co.

By Courtney Sheedy on 10/14/22 9:49 AM

OFIX and SPNE announced a definitive agreement to combine in an all-stock merger of equals. Both companies believe there are meaninful cross-selling revenue synergies, as well as at least $40MM in YoY cost savings to capture over the 3 years following the transaction. The companies have expressed revenue goals of ~$1.0B concluding year 3 post-merger.

Looking forward, the new organization will be a spine and orthopedics company with complementary portfolios in biologics, spinal hardware, bone growth therapies, orthopedic solutions and enabling surgical technologies. SmartTRAK notes that once merged, the new company will be strategically positioned in high-growth emerging technology, including cervical disc replacement with M6-C, enabling technology with 7D’s FLASH Navigation System and OrthoNext preop planning, and with focused development in spine and limb within pediatrics. Additionally, the new company will have a highly competitive offering in the spinal interbody space with its WaveForm 3D and NanoMetalene technologies. Together, the combined company’s biologics portfolio will also represent one of the broadest offerings available in spine and orthopedics.

Find out how to receive SmartTRAK Daily Updates in your morning email

SmartTRAK believes the complimentary product portfolios provide a comprehensive offering and

Continue Reading
3 min read

Astura Medical Reveals New Products Launching at NASS 2022: An Interview with CEO Joel Gambrell

By Courtney Sheedy on 10/12/22 10:02 AM

 In an interview with SmartTRAK, Joel Gambrell, Co-founder and CEO for Astura Medical, shares the series of new products launching at NASS and, specifically, reveals what makes Astura’s new Integrated Expandable ALIF System, El Capitan, truly differentiated.

Since the Company was founded in 2014, Astura Medical has achieved fast growth, established a reputation for elegance and quality in its product offering and taken a different methodology to both product development and business operations. In an interview with SmartTRAK, Joel Gambrell, Co-founder and CEO, provides insight on how Astura’s R&D process is unique, unveils why Astura’s approach to custom implants offers the most real-time precision and reveals the distinctions that make the new Integrated Expandable ALIF System, El Capitan, truly differentiated. In addition to El Capitan, Astura Medical will be launching several other new technologies at the North American Spine Society’s (NASS) annual 2022 meeting in Chicago. 

SmartTRAK's spine experts will be roaming the floor at NASS 2022, bringing our subscribers real-time news direct from the show. We'll also be on the show floor at booth #2341, ready to answer your questions, share insights on the latest news and innovations in the Spine Market and discuss how SmartTRAK can help you Be the Expert in your market.  If you would like to book a meeting with us at NASS, just click here.

Continue reading to find out how to download a complete transcript of SmartTRAK's interview with CEO Joel Gambrell.

Continue Reading
  • There are no suggestions because the search field is empty.

Follow Us on Social Media

Recent Articles